Jennifer A Pereira1, Allison McGeer2, Antigona Tomovici2, Alex Selmani2, Ayman Chit2. 1. JRL Research and Consulting (Pereira), Mississauga, Ont.; Department of Microbiology (McGeer), Mount Sinai Hospital; Sanofi Pasteur (Tomovici), Toronto, Ont.; Sanofi Pasteur (Selmani, Chit), Swiftwater, Penn. jennifer.pereira@jrlresearch.com. 2. JRL Research and Consulting (Pereira), Mississauga, Ont.; Department of Microbiology (McGeer), Mount Sinai Hospital; Sanofi Pasteur (Tomovici), Toronto, Ont.; Sanofi Pasteur (Selmani, Chit), Swiftwater, Penn.
Abstract
BACKGROUND: Understanding the impact of prevention programs on Clostridioides difficile infection rates is important, and decisions on future program changes, including how to use vaccines currently in development, requires a detailed understanding of the epidemiologic features of C. difficile infection. We analyzed Ontario health administrative data to determine incidence rates and medical costs of C. difficile infection, based on whether acquisition and onset occurred in acute care hospitals (ACHs), long-term care facilities or the community. METHODS: We performed a retrospective analysis using individual-level data from Ontario health databases from Apr. 1, 2005, to Mar. 31, 2015, identifying rates of C. difficile infection requiring hospital admission per 100 000 person-years in adults aged 18 years or more for categories of acquisition and onset. We estimated health care system costs of infection 180 and 365 days after admission by matching patients with C. difficile infection with control patients with similar characteristics. RESULTS: Over the study period, 33 909 people in Ontario were admitted to hospital with C. difficile infection; 17 272 cases (50.9%) were associated with ACHs. The number of cases per 100 000 person-years ranged from 27.7 in 2009/10 to 37.0 in 2012/13. Annually, the highest incidence of infection was for ACH-associated/ACH-onset. Community-associated infection became more prevalent over time, rising from 19.4% of cases in 2005/06 to 29.2% in 2014/15. Infection costs were mostly due to hospital admission within 180 days after hospital discharge. Infection associated with ACHs had the highest total costs and the largest cost attributable to C. difficile infection (median $38 953 for infected patients v. $13 542 for control patients). Median costs attributable to C. difficile infection were $1051 for that associated with long-term care facilities, $13 249 for community-associated infection and $11 917 for ACH-associated/community-onset infection. INTERPRETATION: Community-associated C. difficile infection had similar health care cost implications as hospital-associated infection. With rates of community-associated C. difficile infection on the rise, family physicians should be supported to prevent this infection in their patients. Copyright 2020, Joule Inc. or its licensors.
BACKGROUND: Understanding the impact of prevention programs on Clostridioides difficileinfection rates is important, and decisions on future program changes, including how to use vaccines currently in development, requires a detailed understanding of the epidemiologic features of C. difficileinfection. We analyzed Ontario health administrative data to determine incidence rates and medical costs of C. difficileinfection, based on whether acquisition and onset occurred in acute care hospitals (ACHs), long-term care facilities or the community. METHODS: We performed a retrospective analysis using individual-level data from Ontario health databases from Apr. 1, 2005, to Mar. 31, 2015, identifying rates of C. difficileinfection requiring hospital admission per 100 000 person-years in adults aged 18 years or more for categories of acquisition and onset. We estimated health care system costs of infection 180 and 365 days after admission by matching patients with C. difficileinfection with control patients with similar characteristics. RESULTS: Over the study period, 33 909 people in Ontario were admitted to hospital with C. difficileinfection; 17 272 cases (50.9%) were associated with ACHs. The number of cases per 100 000 person-years ranged from 27.7 in 2009/10 to 37.0 in 2012/13. Annually, the highest incidence of infection was for ACH-associated/ACH-onset. Community-associated infection became more prevalent over time, rising from 19.4% of cases in 2005/06 to 29.2% in 2014/15. Infection costs were mostly due to hospital admission within 180 days after hospital discharge. Infection associated with ACHs had the highest total costs and the largest cost attributable to C. difficileinfection (median $38 953 for infectedpatients v. $13 542 for control patients). Median costs attributable to C. difficileinfection were $1051 for that associated with long-term care facilities, $13 249 for community-associated infection and $11 917 for ACH-associated/community-onset infection. INTERPRETATION: Community-associated C. difficileinfection had similar health care cost implications as hospital-associated infection. With rates of community-associated C. difficileinfection on the rise, family physicians should be supported to prevent this infection in their patients. Copyright 2020, Joule Inc. or its licensors.
Authors: Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal Journal: N Engl J Med Date: 2005-12-01 Impact factor: 91.245
Authors: Denise Gravel; Michael Gardam; Geoffrey Taylor; Mark Miller; Andrew Simor; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly; Michael Mulvey Journal: Am J Infect Control Date: 2009-02 Impact factor: 2.918
Authors: Sahil Khanna; Darrell S Pardi; Scott L Aronson; Patricia P Kammer; Robert Orenstein; Jennifer L St Sauver; W Scott Harmsen; Alan R Zinsmeister Journal: Am J Gastroenterol Date: 2011-11-22 Impact factor: 10.864
Authors: Alice Y Guh; Yi Mu; James Baggs; Lisa G Winston; Wendy Bamberg; Carol Lyons; Monica M Farley; Lucy E Wilson; Stacy M Holzbauer; Erin C Phipps; Zintars G Beldavs; Marion A Kainer; Maria Karlsson; Dale N Gerding; Ghinwa Dumyati Journal: Am J Infect Control Date: 2018-01-09 Impact factor: 2.918
Authors: M H Wilcox; N Shetty; W N Fawley; M Shemko; P Coen; A Birtles; M Cairns; M D Curran; K J Dodgson; S M Green; K J Hardy; P M Hawkey; J G Magee; A D Sails; M W D Wren Journal: Clin Infect Dis Date: 2012-07-11 Impact factor: 9.079
Authors: Jeffrey C Kwong; Sujitha Ratnasingham; Michael A Campitelli; Nick Daneman; Shelley L Deeks; Douglas G Manuel; Vanessa G Allen; Ahmed M Bayoumi; Aamir Fazil; David N Fisman; Andrea S Gershon; Effie Gournis; E Jenny Heathcote; Frances B Jamieson; Prabhat Jha; Kamran M Khan; Shannon E Majowicz; Tony Mazzulli; Allison J McGeer; Matthew P Muller; Abhishek Raut; Elizabeth Rea; Robert S Remis; Rita Shahin; Alissa J Wright; Brandon Zagorski; Natasha S Crowcroft Journal: PLoS One Date: 2012-09-04 Impact factor: 3.240
Authors: Jennifer C Hunter; Yi Mu; Ghinwa K Dumyati; Monica M Farley; Lisa G Winston; Helen L Johnston; James I Meek; Rebecca Perlmutter; Stacy M Holzbauer; Zintars G Beldavs; Erin C Phipps; John R Dunn; Jessica A Cohen; Johannetsy Avillan; Nimalie D Stone; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa Journal: Open Forum Infect Dis Date: 2016-01-18 Impact factor: 3.835
Authors: Uffe Christian Braae; Frederik Trier Møller; Rikke Ibsen; Steen Ethelberg; Jakob Kjellberg; Kåre Mølbak Journal: Front Public Health Date: 2020-11-26
Authors: Seyed M Hosseini-Moghaddam; Bin Luo; Sarah E Bota; Shahid Husain; Michael S Silverman; Nick Daneman; Kevin A Brown; J Michael Paterson Journal: JAMA Netw Open Date: 2021-12-01
Authors: Camelia Cojocariu; Irina Girleanu; Anca Trifan; Andrei Olteanu; Cristina Maria Muzica; Laura Huiban; Stefan Chiriac; Ana Maria Singeap; Tudor Cuciureanu; Catalin Sfarti; Carol Stanciu Journal: World J Clin Cases Date: 2021-11-26 Impact factor: 1.337
Authors: Tim Du; Kelly B Choi; Anada Silva; George R Golding; Linda Pelude; Romeo Hizon; Ghada N Al-Rawahi; James Brooks; Blanda Chow; Jun C Collet; Jeannette L Comeau; Ian Davis; Gerald A Evans; Charles Frenette; Guanghong Han; Jennie Johnstone; Pamela Kibsey; Kevin C Katz; Joanne M Langley; Bonita E Lee; Yves Longtin; Dominik Mertz; Jessica Minion; Michelle Science; Jocelyn A Srigley; Paula Stagg; Kathryn N Suh; Nisha Thampi; Alice Wong; Susy S Hota Journal: Emerg Infect Dis Date: 2022-04-26 Impact factor: 16.126
Authors: Yi Nong Song; David Yi Yang; Sander Veldhuyzen van Zanten; Karen Wong; Eric McArthur; Claire Zhao Song; Gianluca Ianiro; Giovanni Cammarota; Colleen Kelly; Monika Fischer; Lindsey Russell; Dina Kao Journal: J Can Assoc Gastroenterol Date: 2021-07-23